These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 38786601)

  • 1. Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes.
    Giuliani ME; Bigossi G; Lai G; Marcozzi S; Brunetti D; Malavolta M
    Mar Drugs; 2024 May; 22(5):. PubMed ID: 38786601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seaweeds as Nutraceutical Elements and Drugs for Diabetes Mellitus: Future Perspectives.
    Cotas J; Lomartire S; Pereira L; Valado A; Marques JC; Gonçalves AMM
    Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model.
    Yang SC; Hsu CY; Chou WL; Fang JY; Chuang SY
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in the Discovery and Development of Marine Natural Products with Cardiovascular Pharmacological Effects.
    Zhou JB; Luo R; Zheng YL; Pang JY
    Mini Rev Med Chem; 2018; 18(6):527-550. PubMed ID: 28969542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates on Managing Type 2 Diabetes Mellitus with Natural Products: Towards Antidiabetic Drug Development.
    Alam F; Islam MA; Kamal MA; Gan SH
    Curr Med Chem; 2018; 25(39):5395-5431. PubMed ID: 27528060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotechnological Innovations from Ocean: Transpiring Role of Marine Drugs in Management of Chronic Disorders.
    Bhatia S; Makkar R; Behl T; Sehgal A; Singh S; Rachamalla M; Mani V; Iqbal MS; Bungau SG
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine Microalgal Products with Activities against Age-Related Cardiovascular Diseases.
    Yurika N; Montuori E; Lauritano C
    Mar Drugs; 2024 May; 22(5):. PubMed ID: 38786620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects.
    Rahman MM; Rahaman MS; Islam MR; Rahman F; Mithi FM; Alqahtani T; Almikhlafi MA; Alghamdi SQ; Alruwaili AS; Hossain MS; Ahmed M; Das R; Emran TB; Uddin MS
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SGLT2 Inhibitors and Cardiovascular Outcomes: Do they Differ or there is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL Study.
    Kyriakos G; Quiles-Sanchez LV; Garmpi A; Farmaki P; Kyre K; Savvanis S; Antoniou VK; Memi E
    Curr Cardiol Rev; 2020; 16(4):258-265. PubMed ID: 31362691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural products with potential hypoglycemic activity in T2DM: 2019-2023.
    Fei Z; Xu Y; Zhang G; Liu Y; Li H; Chen L
    Phytochemistry; 2024 Jul; 223():114130. PubMed ID: 38714289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes.
    Paneni F; Lüscher TF
    Am J Med; 2017 Jun; 130(6S):S18-S29. PubMed ID: 28526186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus-Part 1.
    Yandrapalli S; Jolly G; Horblitt A; Pemmasani G; Sanaani A; Aronow WS; Frishman WH
    Cardiol Rev; 2020; 28(4):177-189. PubMed ID: 32282393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade.
    Kocyigit D; Gurses KM; Yalcin MU; Tokgozoglu L
    Endocr Metab Immune Disord Drug Targets; 2017; 17(1):19-31. PubMed ID: 28440199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study.
    Fu AZ; Qiu Y; Radican L; Yin DD; Mavros P
    Cardiovasc Diabetol; 2010 Apr; 9():15. PubMed ID: 20409333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from the past and charting the future of marine natural products drug discovery and chemical biology.
    Gerwick WH; Moore BS
    Chem Biol; 2012 Jan; 19(1):85-98. PubMed ID: 22284357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes.
    Paneni F; Lüscher TF
    Am J Cardiol; 2017 Jul; 120(1S):S17-S27. PubMed ID: 28606340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytochemical, Anti-diabetic and Cardiovascular Properties of Urtica dioica L. (Urticaceae): A Review.
    El Haouari M; Rosado JA
    Mini Rev Med Chem; 2019; 19(1):63-71. PubMed ID: 30246639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Molecular Modeling Investigation of the Therapeutic Potential of Marine Compounds as DPP-4 Inhibitors.
    Antony P; Baby B; Aleissaee HM; Vijayan R
    Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
    Schernthaner G; Schernthaner-Reiter MH; Schernthaner GH
    Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marine natural products with anti-inflammatory activity.
    Cheung RCF; Ng TB; Wong JH; Chen Y; Chan WY
    Appl Microbiol Biotechnol; 2016 Feb; 100(4):1645-1666. PubMed ID: 26711278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.